Tolerability of different first-line treatment (trt) regimens in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC). 31. Mai 2010 Müller, L., Münch, A., Blumenstengel, K., Hutzschenreuther, U., Busies, S., 2010. J Clin Oncol 28(Sup. abstr e15086). doi: 10.1200/jco.2010.28.15_suppl.e15086 Abstract Physicians underestimate the severity of fatigue, stomatitis, HFS and dysgeusia in mRCC-patients on systemic therapy: Interimanalysis of the Fatigue, Mucositis, Hand-Foot-Syndrome, and Dysgeusia in RCC study (FAMOUS). Marschner, N., Münch, A., Lerchenmüller, C., Linz, B., Müller, L., 2010. Onkologie 33 (suppl 6)(P203), 58. doi:10.1159/000321407 Abstract… Weiterlesen Treatment of tumor induced iron deficiency with ferric carboxymaltose (FCM, ferinject®) Steinmetz, T., Tschechne, B., Selak, E., Kellner, T., Schröder, D., Marschner, N., Virgin, G., Kaldeweier, A., 2010. Onkologie 33 (suppl 6)(P250), 74. doi:10.1159/000321409… Weiterlesen